Burghardt E
Wien Klin Wochenschr. 1978 Jul 14;90(14):477-85.
Microcarcinoma in the true sense of the word must be distinguished from so-called early stromal invasion. A clear diagnosis must be based on the histological investigation of an adequate biopsy specimen which encompasses the entire changes and enalbes tumour measurement in all three dimensions. With increasing experience it was recognized that the mortality due to microcarcinoma was very low even when limited surgery was performed. When only clearly defined cases were considered, the mortality was nill in early invasion and merely 1.2% in microcarcinomas with a fictitious volume of up to 500 cmm. Both morphological signs of regression of invasive buds and recent knowledge of tumour immunology point to the effectiveness of immunological defence reactions, which are directly related to the tumour mass. A correctly diagnosed microcarcinoma represents a still-localized disease process unless other speical criteria such as lymphatic invasion point to the possibility of discontinuous spread. The method of treatment must be chosen between the extremes: When the danger of metastasis may be neglected local excision of the total diseased area will suffice; in the opposite case, radical operation with lymphadenectomy is indicated. Limited treatment of a microcarcinoma is only justified following clear definition of the lesion based on adequately removed and histologically accurately analyzed biopsy material.
真正意义上的微癌必须与所谓的早期间质浸润相区分。明确的诊断必须基于对足够活检标本的组织学检查,该标本应涵盖全部病变并能在三维空间内测量肿瘤大小。随着经验的增加,人们认识到即使进行有限的手术,微癌导致的死亡率也非常低。仅考虑明确界定的病例时,早期浸润的死亡率为零,而虚拟体积达500立方毫米的微癌死亡率仅为1.2%。侵袭性芽的消退形态学迹象以及肿瘤免疫学的最新知识都表明免疫防御反应的有效性,这与肿瘤大小直接相关。除非有其他特殊标准,如淋巴浸润提示存在不连续扩散的可能性,否则正确诊断的微癌代表仍处于局部病变阶段。治疗方法必须在两个极端之间选择:当转移风险可忽略不计时,局部切除整个病变区域即可;反之,则需进行根治性手术并清扫淋巴结。只有在基于充分切除并经组织学准确分析的活检材料明确界定病变后,对微癌进行有限治疗才是合理的。